Dr. Bruce Given has served as COO of Arrowhead Research, Inc (Nasdaq: ARWR) since October 2011. Dr. Given retired as chairman of the board for ICON (Nasdaq: ICLR) in 2013 and was CEO of Leonardo Biosystems from 2010 to 2013. Until June of 2007, Dr. Given served as president and chief executive officer and as a member of the board of directors of Encysive Pharmaceuticals, which he joined in 2002. Prior to joining Encysive, he was with Johnson & Johnson for nine years, serving in several capacities including president, International, Ortho-Clinical Diagnostics and as Group Vice President, head of U.S. marketing & sales, research & development for Janssen Pharmaceutica. He held various executive and senior management positions at Sandoz Pharma, Sandoz Research Institute, and Schering-Plough Corporation. Dr. Given serves on the boards of directors for Calando Pharmaceuticals, Pulmotect, and BioHouston and on the scientific advisory boards for inCube and Vapogenix. He previously served as a member of the CPRIT Commercialization Committee, the Texas Life Sciences Committee, and the Technology Review Committee of MD Anderson Medical Center.